Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,350 | 27,620 | 27,890 | 25,080 | 27,260 |
| Marketable Securities | 51,660 | 18,130 | 19,140 | 21,830 | 25,430 |
| Receivables | 9,770 | 65,060 | 63,290 | 70,970 | 65,230 |
| Inventories | 5,360 | 35,770 | 36,420 | 33,920 | 37,250 |
| Other current assets | 25,580 | 10,800 | 11,470 | 7,290 | 6,530 |
| TOTAL | $101,720 | $157,380 | $158,210 | $159,090 | $161,700 |
| Non-Current Assets | |||||
| Investments And Advances | 57,120 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 51,200 | 253,560 | 256,810 | 244,690 | 243,900 |
| TOTAL | $108,320 | $253,560 | $256,810 | $244,690 | $243,900 |
| Total Assets | $223,490 | $431,640 | $435,620 | $423,500 | $425,530 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 710 | 750 | 770 | 760 | 790 |
| Accounts payable and accrued liabilities | 10,020 | 51,270 | 45,910 | 53,610 | 57,950 |
| Other current liabilities | 5,570 | 5,710 | 6,640 | 0 | 0 |
| TOTAL | $16,310 | $63,450 | $62,370 | $57,880 | $62,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 700 | 99,140 | 100,700 | 105,950 | 135,740 |
| Other Non-Current Liabilities | 19,130 | 122,890 | 119,790 | 111,340 | 106,970 |
| TOTAL | $28,290 | $231,430 | $229,870 | $227,410 | $253,790 |
| Total Liabilities | $44,610 | $294,890 | $292,260 | $285,310 | $316,000 |
| Shareholders' Equity | |||||
| Common Shares | 168,460 | 168,420 | 168,420 | 168,250 | 130,340 |
| Retained earnings | -10,110 | -54,150 | -47,640 | -46,080 | -43,220 |
| Other shareholders' equity | 14,300 | 16,690 | 17,350 | 11,350 | 11,940 |
| TOTAL | $178,870 | $136,740 | $143,350 | $138,180 | $109,530 |
| Total Liabilities And Equity | $223,480 | $431,630 | $435,610 | $423,490 | $425,530 |